Epinephrine Market, By Product Type (Auto-Injector, Prefilled Syringes, Ampoules & Vials), By Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2025)

Epinephrine Market growth is expected to gain high momentum during the forecast period due to increasing heart and respiratory diseases. Epinephrine, also known as adrenaline, is a hormone secreted by the adrenal gland in the human body. It helps the human body respond in fight or flight situations of the cells, by increasing the output of the heart thereby increasing the blood flow to the muscles. Epinephrine also acts as a neurotransmitter, which transmits signals across a chemical synapse such as the neuromuscular junction, from one nerve cell to another.

Epinephrine is also used as a medication to treat various conditions such as anaphylaxis, superficial bleeding, and cardiac arrest. Inhaling adrenaline helps treat respiratory conditions such as croup and asthma.

The increasing occurrences of anaphylaxis related to food allergies are driving the epinephrine market. According to the European Academy of Allergy & Clinical Immunology (EAACI), more than 17 million people were affected by food allergies in the year 2013. Moreover, according to the Center for Disease Control and Prevention (CDC), food allergies among children have increased by 50% in the past 10 years.

The market is also growing due to the availability of cost-effective epinephrine products. For instance, in December 2016, Mylan Inc. (US) introduced an authorized alternative of Epipen Autoinjectors with a different packaging and same formulation, which was sold at a price 50% lower than other brands.

Epinephrine is also growing its market due to the increasing cases of asthma and other chronic respiratory disease and cardiac arrests due to increased smoking and other unhealthy habits. According to the World Health Organization (WHO), in 2018, more than 1 billion people worldwide were affected by respiratory diseases among which, asthma is a major contributor.

North America leads the global epinephrine market owing to the increase in heart and respiratory diseases. One of the main reasons for this is unhealthy eating habits and increasing obesity in America.

Key Factors Impacting Market Growth:

  • Food-related diseases in children causing anaphylaxis
  • Increasing heart and respiratory diseases
  • Release of cost-effective epinephrine products

Key Developments:

  • In July 2018, INSYS Therapeutics Inc. demonstrated the results of its epinephrine nasal spray as a potential needle-free, non-invasive and easy to use alternative to intramuscular injection for the treatment of Anaphylaxis.
  • In August 2018, Teva Pharmaceuticals received FDA approval for the first generic epinephrine for emergency treatment of allergic reactions including anaphylaxis in adults and kids above 33 pounds in weight.
  •  In September 2018, Walgreens and Kaleo entered into a partnership under which AUVI-Q which is an auto-injector of epinephrine would be available at all pharmacies across the U.S.

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the epinephrine market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for epinephrine market during the forecast period. 

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for epinephrine market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for epinephrine market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for epinephrine during the forecast period.

Companies Covered: Mylan Inc., Impax, Lincoln Medical Ltd., ALK ABELLO, Sanofi SA, Amphastar, Emerade, Tianjin Jinyao Group, and Harvest Pharmaceuticals 

Market Segmentation:

By Product Type:

  • Auto-Injector
  • Prefilled Syringes
  • Ampoules & Vials

By Application:

  • Anaphylaxis
  • Cardiac Arrest
  • Superficial Bleeding
  • Respiratory Disorders
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Product Type
    • By Application
    • By Distribution Channel
  • Eastern Europe:
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Product Type
    • By Application
    • By Distribution Channel
  • Western Europe:
    • By Country (Germany, UK, France, Spain, Rest of Western Europe)
    • By Product Type
    • By Application
    • By Distribution Channel
  • Middle East:
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Product Type
    • By Application
    • By Distribution Channel
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Product Type
    • By Application
    • By Distribution Channel
  • Rest of the World
    • By Region (South America, Africa)
    • By Product Type
    • By Application
    • By Distribution Channel

Reasons To Buy This Report:

  • Market size estimation of the epinephrine market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com